No difference in radiologic outcomes for natalizumab patients on extended interval dosing compared with standard interval dosing in MS PATHS

被引：0
|
作者：
Ryerson, Lana Zhovtis [1 ]
Naismith, Robert T. [2 ]
Krupp, Lauren B. [1 ]
Charvet, Leigh [1 ]
Liao, Shirley [3 ]
Fisher, Elizabeth [3 ]
De Moor, Carl [3 ]
Williams, James R. [3 ]
Licata, Stephanie [3 ]
Campbell, Nolan [3 ]
机构：
[1] NYU, Dept Neurol, NYU Langone Hlth, New York, NY 10003 USA
[2] Washington Univ, Dept Neurol, St Louis, MO 14263 USA
[3] Biogen, Cambridge, MA USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1964
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Extended dosing interval reduces risk of natalizumab-related PML
    Reactions Weekly, 2019, 1772 (1) : 9 - 9
  • [42] Mri activity and extended interval of natalizumab dosing: a multicenter italian study
    Clerico, M.
    De Mercanti, S. F.
    Signori, A.
    Iudicello, M.
    Cordioli, C.
    Signoriello, E.
    Lus, G.
    Bonavita, S.
    Lavorgna, L.
    Maniscalco, G. T.
    Curti, E.
    Lorefice, L.
    Cocco, E.
    Nociti, V.
    Mirabella, M.
    Baroncini, D.
    Mataluni, G.
    Landi, D.
    Petruzzo, M.
    Lanzillo, R.
    Gandoglia, I.
    Laroni, A.
    Frangiamore, R.
    Sartori, A.
    Cavalla, P.
    Costantini, G.
    Sormani, M. P.
    Capra, R.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 538 - 538
  • [43] Real world effectiveness of Natalizumab extended interval dosing in a French cohort
    Pelle, J.
    Briant, A.
    Lebrun-Frenay, C.
    Cohen, M.
    Mondot, L.
    De Seze, J.
    Bigaut, K.
    Collongues, N.
    Kremer, L.
    Ricard, D.
    Bompaire, F.
    Sallansonnet-Froment, M.
    Ohlmann, C.
    Ciron, J.
    Biotti, D.
    Pignolet, B.
    Parienti, J.
    Defer, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 207 - 207
  • [44] Ocrelizumab extended interval dosing compared to standard dosing - a safe alternative with significantly decreased immunoglobulin M deficiency rates
    Rempe, T.
    Elfasi, A.
    Rodriguez, E.
    Vasquez, M.
    Graves, J.
    Kinkel, R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 958 - 959
  • [45] Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
    Clerico, Marinella
    De Mercanti, Stefania Federica
    Signori, Alessio
    Iudicello, Marco
    Cordioli, Cinzia
    Signoriello, Elisabetta
    Lus, Giacomo
    Bonavita, Simona
    Lavorgna, Luigi
    Maniscalco, Giorgia Teresa
    Curti, Erica
    Lorefice, Lorena
    Cocco, Eleonora
    Nociti, Viviana
    Mirabella, Massimiliano
    Baroncini, Damiano
    Mataluni, Giorgia
    Landi, Doriana
    Petruzzo, Martina
    Lanzillo, Roberta
    Gandoglia, Ilaria
    Laroni, Alice
    Frangiamore, Rita
    Sartori, Arianna
    Cavalla, Paola
    Costantini, Gianfranco
    Sormani, Maria Pia
    Capra, Ruggero
    NEUROTHERAPEUTICS, 2020, 17 (01) : 200 - 207
  • [46] Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
    Marinella Clerico
    Stefania Federica De Mercanti
    Alessio Signori
    Marco Iudicello
    Cinzia Cordioli
    Elisabetta Signoriello
    Giacomo Lus
    Simona Bonavita
    Luigi Lavorgna
    Giorgia Teresa Maniscalco
    Erica Curti
    Lorena Lorefice
    Eleonora Cocco
    Viviana Nociti
    Massimiliano Mirabella
    Damiano Baroncini
    Giorgia Mataluni
    Doriana Landi
    Martina Petruzzo
    Roberta Lanzillo
    Ilaria Gandoglia
    Alice Laroni
    Rita Frangiamore
    Arianna Sartori
    Paola Cavalla
    Gianfranco Costantini
    Maria Pia Sormani
    Ruggero Capra
    Neurotherapeutics, 2020, 17 : 200 - 207
  • [47] Natalizumab extended interval dosing: what about wearing-off effect?
    Bernardes, Catarina
    Fernandes, Catarina
    Cunha, Carolina
    Nunes, Carla
    Macario, Carmo
    Sousa, Livia
    Batista, Sonia
    Correia, Ines
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 458
  • [48] MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study
    De Mercanti, Stefania Federica
    Signori, Alessio
    Cordioli, Cinzia
    Signoriello, Elisabetta
    Lus, Giacomo
    Bonavita, Simona
    Abbadessa, Gianmarco
    Lavorgna, Luigi
    Maniscalco, Giorgia Teresa
    Curti, Erica
    Lorefice, Lorena
    Cocco, Eleonora
    Nociti, Viviana
    Mirabella, Massimiliano
    Baroncini, Damiano
    Mataluni, Giorgia
    Landi, Doriana
    Petruzzo, Martina
    Lanzillo, Roberta
    Gandoglia, Ilaria
    Laroni, Alice
    Frangiamore, Rita
    Sartori, Arianna
    Cavalla, Paola
    Costantini, Gianfranco
    Capra, Ruggero
    Sormani, Maria Pia
    Clerico, Marinella
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 424
  • [49] Natalizumab extended interval dosing: what about wearing-off effect?
    Bernardes, Catarina
    Fernandes, Catarina
    Cunha, Carolina
    Batista, Sonia
    Nunes, Carla
    Macario, Maria do Carmo
    Sousa, Livia Maria
    Correia, Ines
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1010 - 1011
  • [50] sNFL applicability as additional monitoring tool in Natalizumab Extended Interval Dosing regimen for RRMS patients
    Valentino, P.
    Malucchi, S.
    Martire, S.
    Bava, C. I.
    Capobianco, M. A.
    Bertolotto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 1006 - 1007
12345